CClinicalTrials.gg
CompletedNCT06190795Updated Sep 10, 2025

A Smartphone Application for a Self-directed Upper Limb Therapy After Stroke

An interventional study of AMPLIFY Smartphone Application and Hardcopy Manual in Stroke, sponsored by Tan Tock Seng Hospital. Completed at 1 site in Singapore. Open to participants aged 21 Years to 90 Years. Per ClinicalTrials.gov, last updated 2025-09-10.

Sponsored by Tan Tock Seng Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
21 Years to 90 Years
Sex
All
01

Study summary

The aim of study is to investigate a newly developed AI smartphone application's feasibility, usefulness in improving users' experience, effect on adherence, UL use and recovery after stroke. The study is a prospective randomized controlled trial (RCT) to compare the implementation of AMPLIFY, a self-directed UL programme for people with stroke in two modes of delivery- hardcopy manual versus the mobile application. Eighty people with stroke within 4 weeks of stroke will be randomly allocated to either the experimental group (smartphone app) or control group (hardcopy manual) to undergone four weeks of AMPLIFY program. To compare the clinical effects of delivery AMPLIFY program via smartphone app versus hardcopy manual, assessments will be done at three time points- pre-intervention, post-intervention and three months post-intervention.

Read the detailed description

Background To intensify practice to influence neuroplasticity to optimize UL recovery after stroke, it is important to empower people with stroke to perform self-directed UL therapy outside therapy. However, it has been found that increasing UL practice is often challenging with high level of inactivity found in people with stroke during rehabilitation. Traditionally, self-directed program has been delivered via hard copy manuals. Hardcopy manuals are often cumbersome and difficult to retrieve and handle, especially for those with moderate/severe UL impairment. Hence a more accessible format of exercise/activities instructions is needed. There is lack of reminders for people with stroke to keep up to prescribed exercise regime. This may affect adherence as some may not remember the prescribed practice sessions. Without immediate feedback of UL movement performed during self-practice, people with stroke may continue with compensatory movement performance without correction. This may in turns hinder UL recovery.

The aim of this study is to overcome these challenges by developing an AI-powered interactive smartphone application called AMPLIFY app that enables prescription and progression of exercises/functional activities, while offering immediate feedback on UL movement performed, real-time logging and monitoring of adherence through virtual platform. The inherent interactive nature of app offers features to engage and remind people with stroke to use their paretic UL. This app offers remote monitoring and supervision by therapists without need for actual therapists' physical presence. As the AMPLIFY app is a newly developed AI-powered interactive smartphone application, it is important to investigate the app's feasibility, usefulness in improving users' experience, effect on adherence, UL use, recovery and cost-effectiveness.

Aim:

To Investigate:

  1. Feasibility of AMPLIFY app in completing self-directed UL therapy programme
  2. Usefulness of AMPLIFY app in improving the users' experience in self-directed UL therapy programme performance
  3. Effectiveness of AMPLIFY app in increasing adherence in self-directed UL therapy programme performance
  4. Effectiveness of AMPLIFY app in increasing UL use, confidence and improving recovery after stroke
  5. Cost-effectiveness of AMPLIFY app in reducing the need for clinical review in self-directed UL therapy programme performance

Methods:

The study is a prospective randomized controlled trial (RCT) to compare the implementation of AMPLIFY programme in two modes of delivery- smartphone app versus hardcopy manuals to investigate the aims mentioned above.

People with stroke who fit into the inclusion and exclusion criteria will be invited to participate in the study via informed consent by the research assistant (RA)/ study team members. Once the informed consent has been given by the participants, the participants will undergo the pre-intervention assessment. After the pre-intervention assessment, the participants will be randomised either to the experimental group (AMPLIFY programme via the smartphone app) or control group (AMPLIFY programme via the hardcopy manuals). The intervention of experimental and control arms are described below. Both groups essentially undergo the same AMPLIFY programme but via different modes. Time points of assessment: pre-intervention, post-intervention and post-3months intervention assessments.

Experimental arm Assigned intervention The AMPLIFY Programme will be delivered via smartphone application with two levels. Level 1 is catered for people with stroke with Action Research Arm Test (ARAT) score \<34, while Level 2 is catered for people with stroke with ARAT score >=34. Level 1 consists of six warm up exercises, six strengthening exercises and ten functional activities. Level 2 consists of three warm up exercises, four strengthening exercises, nine hand coordination and dexterity exercises, and ten functional activities. Five to six exercises (including at least one functional activity) will be prescribed to the stroke participants for each session to be performed independently or with the help of caregiver. Stroke participants are to performed the exercises/functional activities three sessions per day (i.e. morning, afternoon, evening) and for six days per week. In addition, the stroke participants are to use their paretic UL to perform the functional activities prescribed to them whenever needed throughout the day. The AMPLIFY programme will last for four weeks. If the stroke participants are discharged before the AMPLIFY programme ends, the participants will continue with the programme at home with the reviews being performed by the therapists via tele-rehabilitation. Frequency of reviews for the experimental group will be as follows: Week1 (2x); Week2 (1x); Week3 (x0); Week4 (x1).

Control arm Assigned intervention The AMPLIFY Programme consists of two booklets (Booklet 1 and Booklet 2). Booklet 1 is catered for people with stroke with ARAT score \<34, while Booklet 2 is catered for people with stroke with ARAT score >=34. Booklet 1 consists of six warm up exercises, six strengthening exercises and ten functional activities. Booklet 2 consists of three warm up exercises, four strengthening exercises, nine hand coordination and dexterity exercises, and ten functional activities. Five to six exercises (including at least one functional activity) will be prescribed to the stroke participants for each session to be performed independently or with the help of caregiver. Stroke participants are to performed the exercises/functional activities three sessions per day (i.e. morning, afternoon, evening) and for six days per week. In addition, the stroke participants are to use their paretic UL to perform the functional activities prescribed to them whenever needed throughout the day. The AMPLIFY programme will last for four weeks. If the stroke participants are discharged before the AMPLIFY programme ends, the participants will continue with the programme at home with the reviews being performed by the therapists via tele-rehabilitation. Frequency of reviews for the control group will be as follows: Week1 (3x); Week2 (2x); Week3 (x1); Week4 (x1).

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Upper Limb
  • Therapy
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 38 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Tan Tock Seng Hospital is the lead sponsor of 103 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis of stroke (confirmed by CT/MRI scans)
  • ≤four weeks post-stroke
  • Montreal Cognitive Assessment (MOCA)>=21
  • Finger extension Medical Research Council (MRC) >=1
  • Fugl Meyer Upper Limb score \<60 or NIHSS Motor Arm section score>=2
  • Potential discharge to home (able to do tele-rehabilitation for review)

Exclusion criteria

Exclusion Criteria:

  • Bilateral stroke
  • Montreal Cognitive Assessment (MOCA)\<21
  • Paretic upper limb numeric pain rating scale (NPRS)>5
  • Reduced paretic upper limb use prior to stroke episode (e.g. frozen shoulder, fracture, etc)
  • Reduced paretic upper limb use due to orthopaedic problems such as fracture in existing stroke episode
  • Medically unstable
  • Neglect as ascertained by treatment team
  • Severe behavioural disturbance or agitation or epilepsy or untreated depression or psychiatric conditions
  • Pregnancy or lactation states
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
38 participants (actual)

Study arms

  • Experimental
    Smartphone Application

    AMPLIFY Programme delivered via smartphone application with 2 levels. Level 1 is catered for people with stroke with ARAT score \<34, while Level 2 is catered for people with stroke with ARAT score \>=34. Five to 6 exercises will be prescribed to the stroke participants for each session to be performed independently or with the help of caregiver. Stroke participants are to performed exercises 3 sessions per day for 6 days per week. Stroke participants are to use paretic UL to perform functional activities prescribed whenever needed throughout the day. AMPLIFY programme will last for 4 weeks. If the stroke participants are discharged before 4 weeks, the participants will continue at home with the reviews being performed by the therapists via tele-rehabilitation. Frequency of reviews for the experimental group will be: Week1 (2x); Week2 (1x); Week3 (x0); Week4 (x1).

    Other: AMPLIFY Smartphone Application

  • Active comparator
    Hardcopy Manual

    AMPLIFY Programme will be delivered via hardcopy manual. AMPLIFY Programme consists of two booklets (Booklet 1 and Booklet 2). Booklet 1 is catered for people with stroke with ARAT score \<34, while Booklet 2 is catered for people with stroke with ARAT score \>=34. Five to 6 exercises will be prescribed to the stroke participants for each session to be performed independently or with the help of caregiver. Stroke participants are to performed the exercises 3 sessions per day for 6 days per week. Stroke participants are to use paretic UL to perform functional activities prescribed whenever needed throughout the day. AMPLIFY programme will last for 4 weeks. If stroke participants are discharged before AMPLIFY programme ends, the participants will continue at home with the reviews being performed by the therapists via tele-rehabilitation. Frequency of reviews for the control group will be as follows: Week1 (3x); Week2 (2x); Week3 (x1); Week4 (x1).

    Other: Hardcopy Manual

Interventions

  • OtherAMPLIFY Smartphone Application

    AMPLIFY Smartphone Application enables prescription and progression of exercises/functional activities, while offering immediate feedback on upper limb movement performed, real-time logging and monitoring of adherence through virtual platform

  • OtherHardcopy Manual

    Hardcopy Manual

06

What researchers measure

Primary outcomes

  1. Change in Action Research Arm Test

    Change in Action Research Arm Test (minimum score 0 - maximum score 57; the higher the score the better the upper limb performance)

    Time frame: Change from pre-intervention to immediate post-intervention

Secondary outcomes

  1. Change in Action Research Arm Test

    Change in Action Research Arm Test (minimum score 0 - maximum score 57; the higher the score the better the upper limb performance)

    Time frame: Change from immediate post-intervention to 3 month post-intervention

  2. Change in Upper Limb Self-Efficacy Test

    Change in Upper Limb Self-Efficacy Test (minimum score 0 - maximum score 200; the higher the score the higher the level of self-efficacy in upper limb use)

    Time frame: Change from pre-intervention to immediate post-intervention

  3. Change in Upper Limb Self-Efficacy Test

    Change in Upper Limb Self-Efficacy Test (minimum score 0 - maximum score 200; the higher the score the higher the level of self-efficacy in upper limb use)

    Time frame: Change from immediate post-intervention to 3 month post-intervention

  4. Change in Rating of Everyday Arm-use in the Community and Home

    Change in Rating of Everyday Arm-use in the Community and Home (minimum score 0 -maximum score 5; the higher the score the higher the level of upper limb use)

    Time frame: Change from pre-intervention to immediate post-intervention

  5. Change in Rating of Everyday Arm-use in the Community and Home

    Change in Rating of Everyday Arm-use in the Community and Home (minimum score 0 -maximum score 5; the higher the score the higher the level of upper limb use)

    Time frame: Change from immediate post-intervention to 3 month post-intervention

  6. Change in Stroke Rehabilitation Motivation Scale

    Change in Stroke Rehabilitation Motivation Scale (minimum score 28 - maximum score 140; the higher the score the higher the level of motivation)

    Time frame: Change from pre-intervention to immediate post-intervention

  7. Change in Stroke Rehabilitation Motivation Scale (SRMS)

    Change in Stroke Rehabilitation Motivation Scale (minimum score 28 - maximum score 140; the higher the score the higher the level of motivation)

    Time frame: Change from immediate post-intervention to 3 month post-intervention

  8. Change in upper limb pain visual analogue scale

    Change in upper limb pain visual analogue scale (minimum score 0 - maximum score 10; the higher the score the higher the level of upper limb pain)

    Time frame: Change from pre-intervention to immediate post-intervention

  9. Change in upper limb pain visual analogue scale

    Change in upper limb pain visual analogue scale (minimum score 0 - maximum score 10; the higher the score the higher the level of upper limb pain)

    Time frame: Change from immediate post-intervention to 3 month post-intervention

  10. Change in upper limb Modified Ashworth Scale

    Change in upper limb Modified Ashworth Scale (minimum score 0 - maximum score 4; the higher the score the higher the level of upper limb resistance to passive movement)

    Time frame: Change from pre-intervention to immediate post-intervention

  11. Change in upper limb Modified Ashworth Scale

    Change in upper limb Modified Ashworth Scale (minimum score 0 - maximum score 4; the higher the score the higher the level of upper limb resistance to passive movement)

    Time frame: Change from immediate post-intervention to 3 month post-intervention

  12. Feasibility - Number of drop-out

    Number of drop-out from AMPLIFY Programme

    Time frame: Throughout the 4 weeks of intervention

  13. Feasibility- Number of adverse events related to AMPLIFY Programme

    Number of adverse events related to intervention

    Time frame: Throughout the 4 weeks of intervention

  14. AMPLIFY Programme Adherence

    Percentage of adherence to the prescribed AMPLIFY Programme

    Time frame: Throughout the 4 weeks of intervention

  15. Number of upper limb repetitions performed in AMPLIFY Programme

    Number of upper limb repetitions performed in AMPLIFY Programme

    Time frame: Throughout the 4 weeks of intervention

  16. Number of Clinical Reviews in AMPLIFY Programme

    Number of Clinical Reviews in AMPLIFY Programme

    Time frame: Throughout the 4 weeks of intervention

  17. User Experience Survey

    Feedback on user experience on hardcopy manual / smartphone application (minimum score 0 - maximum score 40; the higher the score the higher the ease and satisfaction to the use of the hardcopy manual / smartphone application)

    Time frame: End of 4 weeks intervention

  18. Affinity for Technology Interaction Scale

    Affinity for Technology Interaction Scale (minimum score 1 - maximum score 6; the higher the score the higher the affinity to technology)

    Time frame: Pre-intervention

07

Study locations

1 site
  • Lay Fong Chin
    Singapore, Singapore 307382, Singapore
08

References and documents

Publications

  • Chin LF, Hayward KS, Chai ALM, Brauer SG. A Self-Empowered Upper Limb Repetitive Engagement Program to Improve Upper Limb Recovery Early Post-Stroke: Phase II Pilot Randomized Controlled Trial. Neurorehabil Neural Repair. 2021 Sep;35(9):836-848. doi: 10.1177/15459683211032967. Epub 2021 Jul 19. PubMed 34281405 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06190795
Lead sponsor
Tan Tock Seng Hospital
Responsible party
Sponsor
First posted
Jan 5, 2024
Start date
Mar 11, 2024
Primary completion
Mar 31, 2025
Completion
Mar 31, 2025
Last update
Sep 10, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion